scholarly journals Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update"

2021 ◽  
Author(s):  
Melanie Y. Bertram ◽  
Tessa Tan Torres Edejer
Keyword(s):  
Decision Making ◽  
Cost Effectiveness ◽  
World Health Organization ◽  
Methodological Approach ◽  
Health Benefit ◽  
Cost Effective ◽  
World Health ◽  
Health Coverage ◽  
Health Organization ◽  
Over Time

The WHO-CHOICE (World Health Organization CHOosing Interventions that are Cost-Effective) approach is unique in the global health landscape, as it takes a "generalized" approach to cost-effectiveness analysis (CEA) that can be seen as a quantitative assessment of current and future efficiency within a health system. CEA is a critical contribution to the process of priority setting and decision-making in healthcare, contributing to deliberative dialogue processes to select services to be funded. WHO-CHOICE provides regional level estimates of cost-effectiveness, along with tools to support country level analyses. This series provides an update to the methodological approach used in WHO-CHOICE and presents updated cost-effectiveness estimates for 479 interventions. Five papers are presented, the first focusing on methodological updates, followed by three results papers on maternal, newborn and child health; HIV, tuberculosis and malaria; and non-communicable diseases and mental health. The final paper presents a set of example universal health coverage (UHC) benefit packages selected through only a value for money lens, showing that all disease areas have interventions which can fall on the efficiency frontier. Critical for all countries is institutionalizing decision-making processes. A UHC benefit package should not be static, as the countries needs and ability to pay change over time. Decisions will need to be continually revised and new interventions added to health benefit packages. This is a vital component of progressive realization, as the package is expanded over time. Developing an institutionalized process ensures this can be done consistently, fairly, and transparently, to ensure an equitable path to UHC.

scholarly journals Progressive Realisation of Universal Health Coverage in Low- and Middle-Income Countries: Beyond the "Best Buys"

2021 ◽  
Author(s):  
Melanie Y. Bertram ◽  
Jeremy A. Lauer ◽  
Karin Stenberg ◽  
Ambinintsoa H. Ralaidovy ◽  
Tessa Tan-Torres Edejer
Keyword(s):  
Cost Effectiveness ◽  
Universal Health Coverage ◽  
Treatment Guidelines ◽  
Health Benefit ◽  
Cost Effective ◽  
Sub Saharan Africa ◽  
World Health ◽  
Local Context ◽  
Health Coverage ◽  
Universal Health

Background: World Health Organization Choosing Interventions that are Cost-Effective (WHO CHOICE) has been a programme of the WHO for 20 years. In this latest update, we present for the first time a cross-programme analysis of the comparative cost-effectiveness of 479 intervention scenarios across 20 disease programmes and risk factors. Methods: This analysis follows the standard WHO CHOICE approach to generalized cost-effectiveness analysis applied to two regions, Eastern sub-Saharan Africa and Southeast Asia. The scope of the analysis is all interventions included in programme specific WHO CHOICE analyses, using WHO treatment guidelines for major disease areas as the foundation. Costs are measured in 2010 international dollars, and benefits modelled beginning in 2010, or the nearest year for which validated data was available, both for a period of 100 years. Results: Across both regions included in the analysis, interventions span multiple orders of magnitude in terms of cost-effectiveness ratios. A health benefit package optimized through a value for money lens incorporates interventions responding to all of the main drivers of disease burden. Interventions delivered through first level clinical and non-clinical services represent the majority of the high impact cost-effective interventions. Conclusion: Cost-effectiveness is one important criterion when selecting health interventions for benefit packages to progress towards universal health coverage (UHC), but it is not the only criterion and all calculations should be adapted to the local context. To support country decision-makers, WHO CHOICE has developed a downloadable tool to support the development of data for this criterion.

Post COVID-19 Potentials and Innovation: The Future Supply Chain

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1054-1057
Author(s):  
Bindu Swetha Pasuluri ◽  
Anuradha S G ◽  
Manga J ◽  
Deepak Karanam
Keyword(s):  
Mental Health ◽  
Decision Making ◽  
Supply Chain ◽  
Supply Chains ◽  
World Health Organization ◽  
World Wide ◽  
World Health ◽  
Future Supply ◽  
Entire World ◽  
Health Organization

An unanticipated outburst of pneumonia of inexperienced in Wuhan, , China stated in December 2019. World health organization has recognized pathogen and termed it COVID-19. COVID-19 turned out to be a severe urgency in the entire world. The influence of this viral syndrome is now an intensifying concern. Covid-19 has changed our mutual calculus of ambiguity. It is more world-wide in possibility, more deeply , and much more difficult than any catastrophe that countries and organizations have ever faced. The next normal requires challenging ambiguity head-on and building it into decision-making. It is examined that every entity involved in running supply chains would require through major as employee, product, facility protocols, and transport would have to be in place. It is an urgent need of structuring to apply the lessons well-read for our supply chain setup. With higher managers now being aware of the intrinsic hazards in their supply chain, key and suggestions-recommendations will help to guide leader to commit to a newly planned, more consistent supply chain setup. Besides, the employees’ mental health is also a great concern.

scholarly journals Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

2020 ◽  
Vol 25 (32) ◽  
Author(s):  
Erik Alm ◽  
Eeva K Broberg ◽  
Thomas Connor ◽  
Emma B Hodcroft ◽  
Andrey B Komissarov ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Data Dissemination ◽  
Sequence Data ◽  
Temporal Distribution ◽  
World Health ◽  
European Region ◽  
The World ◽  
Health Organization ◽  
Over Time

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.

scholarly journals Policy Innovation and Policy Pathways: Tuberculosis Control in Sri Lanka, 1948–1990

2016 ◽  
Vol 60 (4) ◽  
pp. 514-533
Author(s):  
Margaret Jones
Keyword(s):  
Sri Lanka ◽  
World Health Organization ◽  
Cost Effective ◽  
Control Programme ◽  
World Health ◽  
Tuberculosis Control ◽  
Organization Model ◽  
Specialist Services ◽  
Bacteriological Test ◽  
Health Organization

This paper, based on World Health Organization and Sri Lankan sources, examines the attempts to control tuberculosis in Sri Lanka from independence in 1948. It focuses particularly on the attempt in 1966 to implement a World Health Organization model of community-orientated tuberculosis control that sought to establish a horizontally structured programme through the integration of control into the general health services. The objective was to create a cost- effective method of control that relied on a simple bacteriological test for case finding and for treatment at the nearest health facility that would take case detection and treatment to the rural periphery where specialist services were lacking. In the late 1940s and early 1950s, Sri Lanka had already established a specialist control programme composed of chest clinics, mass X-ray, inpatient and domiciliary treatment, and social assistance for sufferers. This programme had both reduced mortality and enhanced awareness of the disease. This paper exposes the obstacles presented in trying to impose the World Health Organization’s internationally devised model onto the existing structure of tuberculosis control already operating in Sri Lanka. One significant hindrance to the WHO approach was lack of resources but, equally important, was the existing medical culture that militated against its acceptance.

Is Anorexia Nervosa an Obsessive-Compulsive Disorder?

1990 ◽  
Vol 157 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Neil L. Holden
Keyword(s):  
Anorexia Nervosa ◽  
World Health Organization ◽  
Anterior Pituitary ◽  
World Health ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Clear Cut ◽  
Icd 10 ◽  
Health Organization ◽  
Over Time

Although anorexia nervosa may vary widely in its severity and outcome, it is usually regarded as an illness in its own right, as patients do not display major changes in the form of the illness over time (Russell, 1970). It readily lends itself to being accorded clear-cut diagnostic criteria (Russell, 1977) and this is reflected in ICD–10 (World Health Organization, 1987). However, the nosological independence of anorexia nervosa has undergone vigorous assault since its classic description by William Gull (1874). For example, the psychological nature of anorexia nervosa was obscured for 30 years by Simmond's (1914) description of anterior pituitary lesions and cachexia, and Kay & Leigh's (1954) influential study of anorexia nervosa concluded with their doubts about its status as a ‘psychiatric entity’.

Sign in / Sign up

Export Citation Format

Share Document